Stem Cells in Breast Development and Cancer
Abstract The concept of the stem cell of origin for cancers was first proposed more than 100 years ago. In this theoretical model, certain cells with self-renewal capacity would form…
Abstract The concept of the stem cell of origin for cancers was first proposed more than 100 years ago. In this theoretical model, certain cells with self-renewal capacity would form…
Abstract Breast lymphoma and mesenchymal neoplasms of the breast are rare entities. The large continuum of disease includes fibroepithelial, vascular, lipomatous, neural, myogenic, and osseous neoplasms. In this chapter, we…
Abstract The estrogen receptor (ER) is the most important member of the nuclear receptor superfamily that controls the replication or apoptotic death of selected populations of breast cancer cells. The…
Abstract Traditionally breast cancer has been classified according to morphologic features. Despite emerging era of personalized medicine and availability of molecular testing, the histologic classification remains valuable. Different patterns of…
Abstract Over the past several decades, the widespread adoption of mammographic screening has had a significant impact on the incidence, diagnosis, classification, and treatment of all breast diseases. These changes…
Abstract Organization, more than 20 morphologic subtypes of breast cancer have been recognized. By gene expression, invasive breast cancer is classified into at least four major subtypes; luminal A, luminal…
Abstract We review the evidence that proliferative breast disease increases the risk of breast cancer. Results from six cohorts give consistent estimates of these risks. The combined estimate of the…
Abstract Nipple discharge is a common breast symptom that warrants evaluation. Although most discharges are due to benign conditions, discharge may be due to an underlying malignancy. This chapter reviews…
Abstract Only approximately 10% of breast cancers are caused by identifiable mutations in major breast cancer susceptibility genes. Nevertheless, for families affected by these mutations, genetic testing is a powerful…
Abstract This chapter reviews 20 years of randomized, prospective clinical research on the use of selective hormone receptor modulators and aromatase inhibitors for the reduction of breast cancer risk in…